The report will be delivered in 2-3 business days.

Non-invasive Prenatal Testing Global Market Report 2021: COVID-19 Growth And Change To 2030

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7120 | Format :


The non-invasive prenatal testing market consists of sales of non-invasive prenatal testing kits, instruments and related services. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects in fetus in first trimester of pregnancy. Non-invasive prenatal testing includes ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests and biochemical screening tests.

The non-invasive prenatal testing market covered in this report is segmented by type into consumables, instruments. The non-invasive prenatal testing market is also segmented by end user into hospital, diagnostic labs; by instruments into NGS systems, PCR instruments, microarrays, ultrasound devices, others(centrifuges, UV systems, incubators, microscopes); by consumables into assay kits &reagents, disposables; by application into trisomy, microdeletion, genetics, Rh factor.

The global non-invasive prenatal testing market is expected to grow from $2.17 billion in 2020 to $2.43 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The non-invasive prenatal testing market is expected to reach $4.02 billion in 2025 at a CAGR of 13.4%.

The high incidence rate of Down syndrome is one major factor driving non-invasive prenatal testing (NIPT) market with increase in average maternal age which has led to a concern on the safety about the growth of the fetus. Down syndrome is a chromosomal condition that occurs when an error in cell division results in an extra chromosome 21 and can affect the fetus cognitive ability and physical growth. The NIPT screening tests do not harm the mother or baby, carries no risk of miscarriage as they are non-invasive, and can detect more than 99% of cases of Down syndrome. According to National Down Syndrome Society and Centres for Disease control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome among older women drives the non-invasive prenatal testing market.

The ethical hurdles in the non-invasive prenatal testing (NIPT) market have led to a range of ethical issues in terms of sex selection or aborting babies with chromosomal abnormality. Determining the sex of the fetus or knowing if the baby has an abnormality at an earlier stage led to abortions and resulted as an ethical issue which further led to strict regulations on using such devices. According to Department of Health (UK), there were 3,213 abortions in England and Wales from which 37% of the total abortions consisted of chromosomal abnormality and 80% of the abortions were performed under 10 weeks of pregnancy. These hurdles will restrain the non-invasive prenatal testing market.

Next generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has approved the medical instrument product registration of NGS instrument NextSeq 550AR produced by Annoroad.

The non-invasive prenatal testing market is regulated by several regulations that are governed by multiple international and country specific agencies. For instance, the US Food and Drug Administration (FDA) that issues Laboratory Developed Tests (LDTs) certification and Clinical Laboratory Improvement Amendments (CLIA) certification. The manufacturer needs to obtain a 510(k) premarket notification for in vitro diagnostic test. LDTs and CLIA certification are based on number of tests done during clinical trials. For example: For trisomy 21 (Down syndrome), there is an incidence of 1/1000. Given a target of 100 positive results, at least 100,000 samples would have to be tested to meet the requirements of a 510k. A 510k premarket notification demonstrates that the new product is at least as safe and effective as another legally-marketed device. It is mandatory for manufacturers to register a premarket notification before a new product can be certified as fit for market commercially.

In June 2019, Invitae, a USA based medical genetics company acquired Singular Bio for $55M. This acquisition will further strengthen Invitae's ability to bring genetic information into mainstream medical care. Singular Bio, a USA based company specializing in single-molecule, cell-free DNA analysis that it is developing for non-invasive prenatal testing.

Major players in the non-invasive prenatal testing market are F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc. and PerkinElmer Inc.

The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-invasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global non-invasive prenatal testing market is segmented -

1) By Type: Consumables, Instruments

2) By End User: Hospital, Diagnostic Labs

3) By Instruments: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others (Centrifuges, UV Systems, Incubators, Microscopes)

4) By Consumables: Assay Kits & Reagents, Disposables

5) By Application: Trisomy, Microdeletion, Genetics, Rh Factor

    Table Of Contents

    1. Executive Summary

    2. Non-invasive Prenatal Testing Market Characteristics

    3. Non-invasive Prenatal Testing Market Trends And Strategies

    4. Impact Of COVID-19 On Non-invasive Prenatal Testing

    5. Non-invasive Prenatal Testing Market Size And Growth

    5.1. Global Non-invasive Prenatal Testing Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Non-invasive Prenatal Testing Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Non-invasive Prenatal Testing Market Segmentation

    6.1. Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Consumables

    Instruments

    6.2. Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital

    Diagnostic Labs

    6.3. Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    NGS Systems

    PCR Instruments

    Microarrays

    Ultrasound Devices

    Others(Centrifuges

    UV systems

    Incubators

    Microscopes

    6.4. Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Assay Kits &Reagents

    Disposables

    6.5. Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Trisomy

    Microdeletion

    Genetics

    Rh factor

    7. Non-invasive Prenatal Testing Market Regional And Country Analysis

    7.1. Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Non-invasive Prenatal Testing Market

    8.1. Asia-Pacific Non-invasive Prenatal Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Non-invasive Prenatal Testing Market

    9.1. China Non-invasive Prenatal Testing Market Overview

    9.2. China Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Non-invasive Prenatal Testing Market

    10.1. India Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Non-invasive Prenatal Testing Market

    11.1. Japan Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Non-invasive Prenatal Testing Market

    12.1. Australia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Non-invasive Prenatal Testing Market

    13.1. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Non-invasive Prenatal Testing Market

    14.1. South Korea Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Non-invasive Prenatal Testing Market

    15.1. Western Europe Non-invasive Prenatal Testing Market Overview

    15.2. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Non-invasive Prenatal Testing Market

    16.1. UK Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Non-invasive Prenatal Testing Market

    17.1. Germany Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Non-invasive Prenatal Testing Market

    18.4. France Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Non-invasive Prenatal Testing Market

    19.1. Eastern Europe Non-invasive Prenatal Testing Market Overview

    19.2. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Non-invasive Prenatal Testing Market

    20.1. Russia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Non-invasive Prenatal Testing Market

    21.1. North America Non-invasive Prenatal Testing Market Overview

    21.2. North America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Non-invasive Prenatal Testing Market

    22.1. USA Non-invasive Prenatal Testing Market Overview

    22.2. USA Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Non-invasive Prenatal Testing Market

    23.1. South America Non-invasive Prenatal Testing Market Overview

    23.2. South America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Non-invasive Prenatal Testing Market

    24.1. Brazil Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Non-invasive Prenatal Testing Market

    25.1. Middle East Non-invasive Prenatal Testing Market Overview

    25.2. Middle East Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Non-invasive Prenatal Testing Market

    26.1. Africa Non-invasive Prenatal Testing Market Overview

    26.2. Africa Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles

    27.1. Non-invasive Prenatal Testing Market Competitive Landscape

    27.2. Non-invasive Prenatal Testing Market Company Profiles

    27.2.1. F. Hoffmann-La Roche AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Illumina, Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Laboratory Corporation of America Holdings

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Natera, Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. PerkinElmer, Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Non-invasive Prenatal Testing Market

    29. Non-invasive Prenatal Testing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: China, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: India, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: India, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Japan, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Japan, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Australia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Australia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South Korea, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: UK, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: UK, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: Germany, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: Germany, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: France, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: France, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: Russia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: Russia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: North America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: North America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: USA, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: USA, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: South America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: South America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Brazil, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Middle East, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Africa, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: Africa, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 48: F. Hoffmann-La Roche AG Financial Performance
  • Table 49: Illumina, Inc. Financial Performance
  • Table 50: Laboratory Corporation of America Holdings Financial Performance
  • Table 51: Natera, Inc. Financial Performance
  • Table 52: PerkinElmer, Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: China, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: India, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: India, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Japan, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Japan, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Australia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Australia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: Indonesia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: South Korea, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South Korea, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Western Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: UK, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: UK, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: Germany, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: Germany, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: France, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: France, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Eastern Europe, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: Russia, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: Russia, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: North America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: North America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: USA, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: USA, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: South America, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: South America, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Brazil, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Brazil, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Middle East, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Middle East, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Africa, Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: Africa, Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 48: F. Hoffmann-La Roche AG Financial Performance
  • Figure 49: Illumina, Inc. Financial Performance
  • Figure 50: Laboratory Corporation of America Holdings Financial Performance
  • Figure 51: Natera, Inc. Financial Performance
  • Figure 52: PerkinElmer, Inc. Financial Performance
Global Medication Adherence Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Metabolomics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Soft Tissue Repair Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medical Tourism Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Mycoplasma Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pyrogen Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Antimicrobial Susceptibility Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medical Billing Outsourcing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
CRISPR Technology Market - By Product Type (Cas9 And gRNA, Design Tools, Plasmid And Vector, Other Delivery System Products), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs), By Application (Biomedical, Agriculture, Diagnostics and Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Application (HIV, Hepatitis, Herpes, Influenza, Others), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Application (HIV, Hepatitis, Herpes, Influenza, Others), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Laboratory Information System Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
3D Diagnostic Imaging Services Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Healthcare Reimbursement Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Metabolomics Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Synthetic Biology Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)